I. Monteiro, F. Cordeiro, T. Martins, e C. Medeiros, “PE-041 Impact associated with pertuzumab and trastuzumab SC and IV formulations utilization in metastatic HER2- positive breast cancer patients treated in SUS”, JAFF, vol. 9, nº s. 3, mar. 2025.